Individual Disclosures of the NCCN Multiple Myeloma Panel

Panel Member	Clinical Research Support/Data Safety Monitoring Board	Scientific Advisory Boards, Consultant, or Expert Witness	Promotional Advisory Boards, Consultant, or Speakers Bureau	Date Completed
Melissa Alsina, MD	None	Onyx Pharmaceuticals, Inc.	Onyx Pharmaceuticals, Inc.	1/21/15
Kenneth C. Anderson, MDa	None	Bristol-Myers Squibb Company; Celgene Corporation; Gilead Sciences; Millennium Pharmaceuticals, Inc.; and sanofiaventis U.S.	None	1/23/15
Djordje Atanackovic, MD	Array Biopharma; and sanofi-aventis U.S.	Onyx Pharmaceuticals, Inc.	Celgene Corporation; Millennium Pharmaceuticals, Inc.; and Onyx Pharmaceuticals, Inc.	1/16/15
J. Sybil Biermann, MD	None	None	None	3/25/15
Jason C. Chandler, MD	None	Alexion Pharmaceuticals, Inc.; Bristol- Myers Squibb Company; and Onyx Pharmaceuticals, Inc.	None	1/22/15
Caitlin Costello, MD	None	None	None	4/06/15
Benjamin Djulbegovic, MD, PhD	None	None	None	1/20/15
Henry C. Fung, MD, FACP, FRCP	None	None	Genzyme Corporation; and Seattle Genetics	8/15/15
Cristina Gasparetto, MD	Celgene Corporation	Celgene Corporation; and Millennium Pharmaceuticals, Inc.	None	1/27/15
Kelly Godby, MD	None	None	None	7/23/15
Craig Hofmeister, MD, MPH	None	None	None	3/18/15
Leona Holmberg, MD, PhD	Merck & Co., Inc.; Millennium Pharmaceuticals, Inc.; sanofi-aventis U.S.; and Seattle Genetics	sanofi-aventis U.S.; and Seattle Genetics	None	8/26/15
Sarah Holstein, MD, PhD	None	Celgene Corporation; and Millennium Pharmaceuticals, Inc.	None	6/16/15
Carol Ann Huff, MD	MedImmune Inc.; and Pharmacyclics	Celgene Corporation; Millennium Pharmaceuticals, Inc.; and Novartis Pharmaceuticals Corporation	None	5/08/15
Adetola Kassim, MD, MS	None	None	None	3/18/15
Amrita Y. Krishnan, MDa	Jannsen Pharmaceutica Products, LP; and the University of Iowa	None	Celgene Corporation; Millennium Pharmaceuticals, Inc.; and Onyx Pharmaceuticals, Inc.	01/24/15
Shaji K. Kumar, MD	Celgene Corporation; Millennium Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and sanofi-aventis U.S.	Celgene Corporation; Millennium Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.; sanofi-aventis U.S.; and Skyline Diagnostics	None	3/12/15
Michaela Liedtke, MD	None	Amgen Inc.; and Takeda Pharmaceuticals North America, Inc.	None	4/04/15
Matthew Lunning, DO	None	Celgene Corporation; Genentech, Inc.; Gilead; Juno; Spectrum; and TG therapeutics	None	2/04/15
Noopur Raje, MD	Acetylon; Amgen Inc.; and Eli Lilly and Company	Celgene Corporation; Millennium Pharmaceuticals, Inc.; and Onyx Pharmaceuticals, Inc.	Amgen; and Celegene	1/21/15
Seema Singhal, MD	Abbott Laboratories; Array; Jannsen Pharmaceutica Products, LP; and Onyx Pharmaceuticals, Inc.	Celgene Corporation; and Millennium Pharmaceuticals, Inc.	Celgene Corporation; and Millennium Pharmaceuticals, Inc.	1/23/15
Clayton Smith, MD	NA	NA	NA	Pending
George Somlo, MD	National Cancer Institute	Celgene Corporation; Millennium Pharmaceuticals, Inc.; and Pfizer Inc.	Celgene Corporation; Millennium Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and sanofi-aventis U.S.	1/21/15
Keith Stockerl-Goldstein, MD	None	None	Celgene Corporation; Millennium Pharmaceuticals, Inc.; and Onyx Pharmaceuticals, Inc.	1/21/15
Steven P. Treon, MD, PhD	Jannsen Pharmaceutica Products, LP; Onyx Pharmaceuticals, Inc.; and Pharmacyclics	None	Jannsen Pharmaceutica Products, LP; Onyx Pharmaceuticals, Inc.; and Pharmacyclics	4/07/15
Donna Weber, MD	Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation	None	None	9/26/13
Joachim Yahalom, MD	None	None	None	9/29/15

^aThe following have disclosed that they have an Employment/Governing Board, Patent, Equity, or Royalty conflict: Kenneth Anderson, MD: Actelion Pharmaceuticals Ltd. and OncoPep, Inc. Amrita Krishnan, MD: Celgene Corporation, and Pharmacyclics, Inc. The NCCN Guidelines staff have no conflicts to disclose.